4.7 Article

Melanoma chondroitin sulfate proteoglycan enhances FAK and ERK activation by distinct mechanisms

Journal

JOURNAL OF CELL BIOLOGY
Volume 165, Issue 6, Pages 881-891

Publisher

ROCKEFELLER UNIV PRESS
DOI: 10.1083/jcb.200403174

Keywords

melanoma chondroitin sulfate proteoglycan; FAK; integrin; ERK1/2; cell spreading

Categories

Funding

  1. NCI NIH HHS [R01 CA82295, P01 CA89480, R01 CA082295, P01 CA089480] Funding Source: Medline
  2. NCRR NIH HHS [S10 RR016851] Funding Source: Medline

Ask authors/readers for more resources

Melanoma chondroitin sulfate proteoglycan (MCSP) is an early cell surface melanoma progression marker implicated in stimulating tumor cell proliferation, migration, and invasion. Focal adhesion kinase (FAK) plays a pivotal role in integrating growth factor and adhesion-related signaling pathways, facilitating cell spreading and migration. Extracellular signal-regulated kinase (ERK) I and 2, implicated in tumor growth and survival, has also been linked to clinical melanoma progression. We have cloned the MCSP core protein and expressed it in the MCSP-negative melanoma cell line WM1552C. Expression of MCSP enhances integrin-mediated cell spreading, FAK phosphorylation, and activation of ERK1/2. MCSP transfectants exhibit extensive MCSP-rich microspikes on adherent cells, where it also colocalizes with alpha4 integrin. Enhanced activation of FAK and ERK1/2 by MCSP appears to involve independent mechanisms because inhibition of FAK activation had no effect on ERK1/2 phosphorylation. These results indicate that MCSP may facilitate primary melanoma progression by enhancing the activation of key signaling pathways important for tumor invasion and growth.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available